AngioDynamics to Report Fiscal 2011 Fourth Quarter and Full Year Financial Results and Hold Conference Call on July 14, 20

ALBANY, N.Y.--(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2011 fourth quarter and full year financial results on Thursday, July 14, 2011, after the close of the U.S. financial markets.

Scott Solano, AngioDynamics’ interim Chief Executive Officer, and Joseph Gersuk, Executive Vice President and Chief Financial Officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on July 14, 2011, to discuss the results and to answer questions.

To participate in the live call by telephone, please dial +1 (877) 941-6009.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics’ Web site at To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software. The conference call will also be archived on the Web site.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at


Company Contact:
AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
[email protected]
Investor Relations Contacts:
EVC Group, Inc.
Doug Sherk, 415-568-4887
[email protected]
Greg Gin, 646-445-4801
[email protected]
Media Contact:
EVC Group, Inc.
Chris Gale, 646-201-5431
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Surgery  Health  Biotechnology  Hospitals  Medical Devices  Oncology


Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.